Home / Peptide legality / By country
Are peptides legal in your country?
A sourced, cited answer for every major market. Each page leads with the verdict, then the national medicines framework, a compound-by-compound breakdown, import rules, and the official sources behind every claim.
✓50 countries covered✓Every claim cited✓Reviewed quarterly
50
Countries researched
2
Follow medicines law
48
Tightly restricted
Gray area depends on medicines lawRestricted tight limits
Verdicts reflect how each country regulates peptides under its national medicines and drug-scheduling law. Every page cites official sources and shows when it was last researched. Looking for the US? See legality by state.
Europe22 countries
Austria
Restricted→
Belgium
Restricted→
Czechia
Restricted→
Denmark
Restricted→
Finland
Restricted→
France
Restricted→
Germany
Restricted→
Greece
Restricted→
Hungary
Restricted→
Ireland
Restricted→
Italy
Restricted→
Netherlands
Restricted→
Norway
Restricted→
Poland
Restricted→
Portugal
Restricted→
Romania
Gray area→
Russia
Restricted→
Spain
Restricted→
Sweden
Restricted→
Switzerland
Restricted→
Ukraine
Restricted→
United Kingdom
Restricted→
Middle East & Africa8 countries
Egypt
Restricted→
Israel
Restricted→
Nigeria
Restricted→
Qatar
Restricted→
Saudi Arabia
Restricted→
South Africa
Restricted→
Turkey
Restricted→
United Arab Emirates
Restricted→
Asia-Pacific14 countries
Australia
Restricted→
China
Restricted→
Hong Kong
Restricted→
India
Restricted→
Indonesia
Restricted→
Japan
Restricted→
Malaysia
Restricted→
New Zealand
Restricted→
Philippines
Restricted→
Singapore
Restricted→
South Korea
Restricted→
Taiwan
Restricted→
Thailand
Restricted→
Vietnam
Restricted→
Americas6 countries
Argentina
Restricted→
Brazil
Restricted→
Canada
Restricted→
Chile
Restricted→
Colombia
Restricted→
Mexico
Gray area→
Reviewed quarterly against national regulator guidance, drug-scheduling law, and published enforcement actions. Select a country for the full sourced breakdown.
Related data
- FDA drug shortage tracker →Which peptide drugs are in shortage now, with the FDA-stated cause
- Which peptides are FDA-approved →Approval status for every peptide, from Drugs@FDA
- When peptide drugs go generic →Patent and exclusivity expiry dates from the FDA Orange Book
- Which peptides have clinical evidence →Registered clinical trial counts from ClinicalTrials.gov
- Peptide legality by US state →A sourced verdict for all 50 states
More from Peptides.io
- GLP-1 Treatment Gap Index →Our analysis of where Medicaid access to GLP-1s falls shortest, by state
- The Gray-Market Peptide Report →Our analysis of how unapproved peptides are sold and marketed
- Original research from Peptides.io →Data reports we produce ourselves